Frontiers in Cell-Cycle-Targeting Therapies: Addressing the Heterogeneity of the Cancer Cell Cycle. [PDF]
Ganesan IP, Kiyokawa H.
europepmc +1 more source
CSRP1 is a potential therapeutic targets for DLBCL: A computational analysis and in vitro experiments. [PDF]
Tian W, Jin F, Chen Y, Yang M.
europepmc +1 more source
REV1 Loss Triggers a G2/M Cell-Cycle Arrest Through Dysregulation of Mitotic Regulators. [PDF]
Buntin B +10 more
europepmc +1 more source
DNA damage checkpoints balance a tradeoff between diploid- and polyploid-derived arrest failures. [PDF]
Fujimaki K, Jambhekar A, Lahav G.
europepmc +1 more source
Single cell snapshot analyses under proper representation reveal that epithelial-mesenchymal transition couples at G1 and G2/M. [PDF]
Hu S +9 more
europepmc +1 more source
Synthetic lethality and DNA damage response targeting in cancer stem cells: a comprehensive review. [PDF]
Sayed U +8 more
europepmc +1 more source
The Consequences of DNA Damage in the Early Embryo Are Important for Practical Procedures in Assisted Reproduction. [PDF]
Baran V, Čikoš Š, Fabian D.
europepmc +1 more source
Artificial intelligence in mitotic checkpoint modeling: transforming our understanding of cellular division through machine learning and predictive biology. [PDF]
Ibrahim B.
europepmc +1 more source
A single-arm phase Ib study of personalized peptide-pulsed dendritic cell-based multiple target cytotoxic T lymphocyte immunotherapy in combination with toripalimab as second-line therapy in advanced non-small-cell lung cancer. [PDF]
Zhang W +17 more
europepmc +1 more source
Trachystemon orientalis (L.) G. Don aqueous extract induces cell cycle arrest and apoptosis in MCF-7 breast cancer cells via multi-pathway modulation. [PDF]
Demirel Ozbek Y +6 more
europepmc +1 more source

